Overall, under-expression of ITIH2, COL1A2, TIMP1 and AURKA is associated with longer overall survival of CRC patients; whereas COL1A2 expression correlates with longer CRC free survival. The gene discussed is TIMP1; the disease is colorectal carcinoma.